Allergan Continues at Neutral

Drug Intervention in the News

Drug Intervention: Allergan Continues At Neutral
Moreover, in May 2011, Allergan entered into a licensing agreement with Molecular Partners AG and obtained global rights to MP0112, which is being investigated for the treatment of retinal diseases. We note that Allergan's lead drug, Botox,
Read more on Daily Markets

Drug Intervention: Drug rehab project doing street interventions
By Stabroek staff | 0 Comments | Local | Wednesday, August 24, 2011 The Phoenix Recovery Project (PRP) recently launched a Street-Based Intervention programme that offers meals to drug addicts living on the streets while also providing first line
Read more on Stabroek News

Find More Drug Intervention Information…